1. Home
  2. RPC vs IART Comparison

RPC vs IART Comparison

Compare RPC & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ridgepost Capital Inc. Class A Common Stock

RPC

Ridgepost Capital Inc. Class A Common Stock

N/A

Current Price

$8.72

Market Cap

932.7M

Sector

Finance

ML Signal

N/A

Logo Integra LifeSciences Holdings Corporation

IART

Integra LifeSciences Holdings Corporation

HOLD

Current Price

$13.91

Market Cap

823.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RPC
IART
Founded
1992
1989
Country
United States
United States
Employees
267
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
932.7M
823.8M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
RPC
IART
Price
$8.72
$13.91
Analyst Decision
Buy
Hold
Analyst Count
1
7
Target Price
$11.00
$14.33
AVG Volume (30 Days)
510.2K
954.1K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
1.96%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.82
$4.39
Revenue Next Year
$15.80
$3.40
P/E Ratio
$53.06
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.79
$8.70
52 Week High
$9.32
$16.42

Technical Indicators

Market Signals
Indicator
RPC
IART
Relative Strength Index (RSI) 70.48 72.93
Support Level $6.94 $12.90
Resistance Level N/A $14.38
Average True Range (ATR) 0.32 0.71
MACD 0.09 0.37
Stochastic Oscillator 89.78 89.60

Price Performance

Historical Comparison
RPC
IART

About RPC Ridgepost Capital Inc. Class A Common Stock

Ridgepost Capital Inc, formelrly P10 Inc is a player in the alternative asset management sector, specializing in multi-asset class private market solutions. It offers a range of investment solutions, including specialized funds, separate accounts, secondary investments, direct investments, and co-investments across various asset classes and geographies. These solutions cater to diverse investor needs within the private markets, aiming to deliver superior risk-adjusted returns. With a focus on middle and lower-middle markets, the company's portfolio includes Private Equity, Venture Capital, Impact Investing, and Private Credit. Its Revenue primarily comes from recurring management and advisory fees earned on committed capital, typically locked up for ten to fifteen years.

About IART Integra LifeSciences Holdings Corporation

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.

Share on Social Networks: